ACZ885 (CANAKINUMAB), A NEW IL-1 BETA BLOCKING MONOCLONAL ANTIBODY HAS A BENEFICIAL EFFECT IN CHILDREN WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)

Nicolino Ruperto, Pierre Quartier, Nico Wulffraat, Anna Loy, Richard Mouy, Pat Woo, Berent Prakken, Brigitte Bader-Meunier, Emanuele Noseda, Christiane Rordorf, Alberto Martini

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)I3-I3
JournalRheumatology
Volume48
Publication statusPublished - Apr 2009

Cite this